The patient subsequently continued to deteriorate, and died with hepatic and renal failure. Mazindol, a non-amphetaminergic anorectic agent, was administered for 3 weeks. This variability can be detected by invasive methods and, more recently, using non-invasive methods (Finapres). Clinical features of...